Skip to main content

Table 5 Reason for prescreen fail by race

From: Centralizing prescreening data collection to inform data-driven approaches to clinical trial recruitment

 

American Indian or Alaskan Native

Asian

Black or African American

Caucasian or White

Other

Unknown or not reported

Hawaiian or other Pacific Islander

Total

No longer interested—concerns about burden/duration

1 (100%)

1 (10.0%)

3 (17.6%)

65 (25.4%)

1 (20.0%)

7 (18.0%)

0 (0.0%)

78 (23.9%)

No study partner

0 (0.0%)

1 (10.0%)

1 (5.9%)

7 (2.7%)

1 (20.0%)

0 (0%)

0 (0.0%)

9 (2.8%)

MCI/AD diagnosis

0 (0.0%)

0 (0.0%)

0 (0%)

8 (3.1%)

0 (0.0%)

0 (0%)

0 (0.0%)

8 (2.5%)

Medical exclusion (other than MCI/AD diagnosis)

0 (0.0%)

1 (10.0%)

3 (17.7%)

44 (17.2%)

0 (0.0%)

2 (5.1%)

1 (100.0%)

51 (15.6%)

No longer interested—concerns regarding investigational treatment

0 (0.0%)

0 (0.0%)

0 (0.0%)

10 (3.9%)

0 (0.0%)

2 (5.1%)

0 (0.0%)

12 (3.7%)

No longer interested—concerns regarding radiation

0 (0.0%)

0 (0.0%)

0 (0.0%)

3 (1.2%)

0 (0.0%)

0 (0%)

0 (0.0%)

3 (0.9%)

Contraindications to MRI scanning

0 (0.0%)

0 (0.0%)

2 (11.8%)

8 (3.1%)

0 (0.0%)

1 (2.6%)

0 (0.0%)

11 (3.4%)

Other

0 (0.0%)

7 (70.0%)

8 (47.1%)

121 (47.3%)

4 (80.0%)

28 (71.8%)

0 (00%)

167 (51.1%)

  1. Participants can have more than one reason for prescreen fail and race; the sum (%) may exceed 100% or total number of participants, respectively